Occurrence of extended-spectrum β-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria

被引:54
作者
Park, YJ [1 ]
Park, SY
Oh, EJ
Park, JJ
Lee, KY
Woo, GJ
Lee, K
机构
[1] Catholic Univ Korea, Kangnam St Marys Hosp, Coll Med, Dept Clin Pathol, Seoul 137040, South Korea
[2] Korea Food & Drug Adm, Seoul 137040, South Korea
[3] Yonsei Univ, Coll Med, Dept Lab Med, Seoul 137040, South Korea
关键词
extended-spectrum beta-lactamase; Enterobacter cloacae; Citrobacter freundii; Serratia marcescens; screening criteria;
D O I
10.1016/j.diagmicrobio.2004.11.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We assessed the Occurrence and screening criterion for extended-spectrurn beta-lactamases (ESBLs) among AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens. The 413 isolates (158 E. cloacae, 126 C. fieundii, and 129 S. marcescens) isolated from 11 clinical laboratories in Korea were investigated. ESBL production was confirmed by double-disk synergy test and inhibitor-potentiated diffusion test using ceftazidime (CAZ), cefotaxime (CTX), aztreonam (AZT), and cefepime (FEP) with or without clavulanic acid. One hundred seven isolates (25.9%) were as ESBL producers. Of them, resistance was transferred by conjugation in 82 isolates. In transconjugants, structural genes for CTX-M (53.7%), TEM (46.3%), SHV (29.3%) were found. To evaluate the ESBL screening minimum inhibitory concentration (MIC) criteria, MICs for cefuroxime, CAZ, CTX, AZT, and FEP were determined and cutoff value was selected using receiver operator characteristic curve. The FEP MIC >= 1 mu g/mL had the highest sensitivity (95.3%), specificity (82.7%), and positive (65.8%) and negative predictive values (98.3%). (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:265 / 269
页数:5
相关论文
共 26 条
  • [1] Prevalence of extended-spectrum β-lactamase-producing Enterobacter cloacae in the Asia-Pacific Region:: Results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001
    Bell, JM
    Turnidge, JD
    Jones, RN
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) : 3989 - 3993
  • [2] Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes
    Bonnet, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) : 1 - 14
  • [3] A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE
    BUSH, K
    JACOBY, GA
    MEDEIROS, AA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) : 1211 - 1233
  • [4] Epidemiology of extended-spectrum β-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period
    Cantón, R
    Oliver, A
    Coque, TM
    Varela, MD
    Pérez-Díaz, JC
    Baquero, F
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) : 1237 - 1243
  • [5] TRANSFERABLE PRODUCTION OF PER-1 BETA-LACTAMASE IN PSEUDOMONAS-AERUGINOSA
    DANEL, F
    HALL, IMC
    GUR, D
    AKALIN, HE
    LIVERMORE, DM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (02) : 281 - 294
  • [6] A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France
    De Champs, C
    Sirot, D
    Chanal, C
    Bonnet, R
    Sirot, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) : 3177 - 3179
  • [7] DISSEMINATION OF CEPHALOSPORIN-RESISTANT SERRATIA-MARCESCENS STRAINS PRODUCING A PLASMIDIC SHV TYPE BETA-LACTAMASE IN GREEK HOSPITALS
    GIANNELI, D
    TZELEPI, E
    TZOUVELEKIS, LS
    MENTIS, AF
    NIKOLOPOULOU, C
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (09) : 764 - 767
  • [8] Investigation of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea
    Jeong, SH
    Bae, IK
    Kwon, SB
    Lee, JH
    Jung, HI
    Song, JS
    Jeong, BC
    Kim, SJ
    Lee, SH
    [J]. LETTERS IN APPLIED MICROBIOLOGY, 2004, 39 (01) : 41 - 47
  • [9] Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases:: Prevalence of SHV-12 and SHV-2a in Korea
    Kim, J
    Kwon, Y
    Pai, H
    Kim, JW
    Cho, DT
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (05) : 1446 - 1449
  • [10] TRANSFERABLE RESISTANCE TO CEFOTAXIME, CEFOXITIN, CEFAMANDOLE AND CEFUROXIME IN CLINICAL ISOLATES OF KLEBSIELLA-PNEUMONIAE AND SERRATIA-MARCESCENS
    KNOTHE, H
    SHAH, P
    KRCMERY, V
    ANTAL, M
    MITSUHASHI, S
    [J]. INFECTION, 1983, 11 (06) : 315 - 317